Literature DB >> 31898001

Correction to: PET imaging of sympathetic innervation with [18F]Flubrobenguane vs [11C]mHED in a patient with ischemic cardiomyopathy.

Jason G E Zelt1,2, Lisa M Mielniczuk1,2, Cesare Orlandi3, Simon Robinson3, Tayebeh Hadizad1, Olga Walter1, Linda Garrard1, Rob S B Beanlands1,2, Robert A deKemp4.   

Abstract

At time of initial publication, the USAN Council had assigned the generic name for LMI1195 as Flurobenguan. However, the Council has since changed and finalized this compound name as Flubrobenguane which is recommended as the generic name to be used in the future.

Entities:  

Year:  2020        PMID： 31898001     DOI： 10.1007/s12350-019-02018-x

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


  1 in total

Review 1.  Complementary Role of Combined Indirect and Direct Cardiac Sympathetic (Hyper)Activity Assessment in Patients with Heart Failure by Spectral Analysis of Heart Rate Variability and Nuclear Imaging: Possible Application in the Evaluation of Exercise Training Effects.

Authors:  Ferdinando Iellamo; Marco Alfonso Perrone; Andrea Cimini; Giuseppe Caminiti; Agostino Chiaravalloti; Attilio Parisi; Orazio Schillaci
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.